Browse 183 market data tables and 53 figures spread through 229 pages and in-depth TOC on "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020"
http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
Early buyers will receive 10% customization on reports.

The global oligonucleotide synthesis market is expected to reach USD 1,918.6 Million by 2020 from USD 1,078.1 Million in 2015, at a CAGR of 10.1% during the forecast period.

In this report, the oligonucleotide synthesis market is segmented based on products and services, applications, end users, and regions. On the basis of products and services, the oligonucleotide synthesis market is segmented into synthesized oligonucleotides, reagents, and equipment. Synthesized oligonucleotides are expected to account for the largest share of the oligonucleotide synthesis market in 2015. Growth in this segment is attributed to the increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics. The rising demand for custom oligos also contributes to the growth of the synthesized oligonucleotides market.

Among applications, the research applications segment dominates the market, whereas the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. Among end users, the diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. On the basis of regions, the oligonucleotide synthesis market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to account for the largest share of this market in 2015. However, APAC is expected to grow at the highest CAGR during the forecast period, owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region.

The oligonucleotide synthesis market is highly competitive, with the presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors. Key market players include Agilent Technologies (U.S.), BioAutomation Corporation (U.S.), Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (U.K.), Integrated DNA Technologies (IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), Gen9, Inc. (U.S.), GenScript (U.S.), and Nitto Denko Avecia Inc. (Japan).